Intracranial involvement in newly diagnosed multiple myeloma with TP53 deletion: Two case reports / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
;
(12): 1272-1275, 2018.
Artigo
em Chinês
| WPRIM
| ID: wpr-813104
ABSTRACT
We report two rare cases of multiple myeloma (MM) with dural intracranial disease and TP53 deletion. The two patients presented with skull lytic lesion and dural involvement of myeloma. The association between intracranial involvement in MM and TP53 deletion has not been determined. The two patients received bortezomib-based intensive induction and got good response, just as that reported in literature. MM presenting with dural intracranial disease and TP53 deletion at diagnosis is associated with poor outcome. Multi-drug regime containing bortezomib followed by autologous or allogeneic stem cell transportation would improve the prognosis.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patologia
/
Prognóstico
/
Neoplasias Encefálicas
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Proteína Supressora de Tumor p53
/
Resultado do Tratamento
/
Deleção de Genes
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Bortezomib
Tipo de estudo:
Estudo diagnóstico
/
Estudo prognóstico
Limite:
Humanos
Idioma:
Chinês
Revista:
Journal of Central South University(Medical Sciences)
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS